Episode 7: A View On Spray-Drying mRNA-based Therapies

About this episode

The episode discusses a novel spray-dried mRNA therapy for asthma and its implications for pandemic preparedness.

Delivering mNRA Therapies: A Bullseye for Asthma and Future Pandemics In this episode of A View On, we speak with Carsten Rudolph, CEO and co-founder of Ethris, about a novel spray-dried mRNA therapy that targets local immunity in the lungs. Designed to restore interferon lambda signaling in asthma patients, the therapy is also room temperature-stable and virus-agnostic—making it a promising candidate for pandemic preparedness. Tune in to hear how formulation science, lipid carriers, and inhalable delivery are reshaping the future of respiratory care.

People in this episode

Guest: Carsten Rudolph

Topics covered

• mRNA therapies
• asthma treatment
• pandemic preparedness
• formulation science
• inhalable delivery

Keywords

• mRNA
• spray-drying
• asthma
• local immunity
• interferon lambda
• respiratory care
• lipid carriers

Mentioned in this episode

Organizations: Ethris

More episodes of A view on

• Episode 10: A View On Manufacturing Hard-to-manufacture Molecules · March 30, 2026 · 14 min
• Episode 9: A View On Innovating Drug Development and Manufacturing · December 15, 2025 · 17 min
• Episode 8: A View On Process Analytical Technologies · November 11, 2025 · 19 min
• Episode 6: A View On Improving Microbial Manufacturing · July 2, 2025 · 18 min
• Episode 5: A View On Smart Capsule Technology · May 27, 2025 · 20 min
• Episode 4: A View On Developing Acid Reflux Therapy · March 4, 2025 · 22 min